S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 
S&P 500   4,298.86
DOW   33,876.78
QQQ   354.50
3 EV Stocks You Need To Have On Your Watchlist
"Unknown laser company making HUGE profit from Russia-Ukraine War" (Ad)
Will NIO Partake In China's Economic Awakening?
BJ's Restaurants' Approaching Buy Point As Earnings Surge 150%
66,000% upside on tiny biotech? (Ad)
Cactus Opens The Cash Flow Wellhead With Flexsteel Acquisition 
Tax Software Specialist Vertex In Buy Zone After Base Breakout
Trade Smarter: Discover Hidden Opportunities w/ A.I. (Ad)
How to Choose a Brokerage Account or Online Broker
Will Plug Power’s Deal With Energy Vault Move The Needle? 

Best Penny Stocks Under 50 Cents Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. These penny stocks all have a super-low share price of $0.50 or less and are sorted by average trading volume in dollars. These companies are considered the most actively-traded stocks priced under $0.50.


Faraday Future Intelligent Electric stock logo

#1 - Faraday Future Intelligent Electric

NASDAQ:FFIE
Stock Price: $0.33 (+$0.02)
PE Ratio: -0.29
Market Cap: $352.26 million
Average Trading Volume: 92.22 million shares
Consensus Rating: N/A (0 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
Faraday Future Intelligent Electric Inc. engages in the design, development, manufacture, engineering, sale, and distribution of electric vehicles and related products in the United States and internationally. The company was incorporated in 2014 and is headquartered in Gardena, California.
Bed Bath & Beyond stock logo

#2 - Bed Bath & Beyond

NASDAQ:BBBY
Stock Price: $0.22 (+$0.01)
PE Ratio: -0.01
Market Cap: $92.38 million
Average Trading Volume: 122.76 million shares
Consensus Rating: Sell (0 Buy Ratings, 0 Hold Ratings, 11 Sell Ratings)
Consensus Price Target: $3.70 (1,614.6% Upside)
Bed Bath & Beyond, Inc. engages in the operation of retail stores and retails domestics merchandise and home furnishings. Its products include domestic merchandise and home furnishings such as bed linens and related items, bath items, kitchen textiles, kitchen and tabletop items, fine tabletop, basic house wares, general home furnishings, and consumables. The company was founded by Warren Eisenberg and Leonard Feinstein in 1971 and is headquartered in Union, NJ.
Sorrento Therapeutics stock logo

#3 - Sorrento Therapeutics

NASDAQ:SRNE
Stock Price: $0.36 (+$0.01)
Market Cap: $170.92 million
Average Trading Volume: 52.69 million shares
Consensus Rating: Buy (1 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $9.00 (2,384.8% Upside)
Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. It operates through the Sorrento Therapeutics and Scilex segments. The company was founded by Henry H. Ji in 1989 and is headquartered in San Diego, CA.
Ocugen stock logo

#4 - Ocugen

NASDAQ:OCGN
Stock Price: $0.46 (-$0.01)
PE Ratio: -1.27
Market Cap: $104.93 million
Average Trading Volume: 9.65 million shares
Consensus Rating: Buy (4 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.00 (991.5% Upside)
Ocugen, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies to cure eye diseases. Its product pipeline candidates include OCU400, OCU410, OCU200, and COVAXIN. The firm's modifier gene therapy platform is engaged in addressing retinal diseases, including retinitis pigmentosa, leber congenital amaurosis, and dry age-related macular degeneration. The company was founded by Shankar Musunuri and Uday B. Kompella in 2013 and is headquartered in Malvern, PA.
Core Scientific stock logo

#5 - Core Scientific

NASDAQ:CORZ
Stock Price: $0.36 (-$0.01)
Market Cap: $128.27 million
Average Trading Volume: 11.62 million shares
Consensus Rating: Hold (2 Buy Ratings, 7 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $4.54 (1,163.4% Upside)
Core Scientific, Inc. operates facilities for digital asset mining and colocation services in North America. It provides blockchain infrastructure, software solutions, and services. The company mines digital assets for its own account and provides hosting colocation services for other large-scale miners. It operates in two segments, Equipment Sales and Hosting. The company owns and operates computer equipment that is used to process transactions conducted on one or more blockchain networks in exchange for transaction processing fees rewarded in digital currency assets, commonly referred to as mining; and datacenter facilities to provide colocation and hosting services for distributed ledger technology, also commonly known as blockchain. It also develops blockchain-based platforms and applications, including infrastructure management, security technologies, mining optimization, and recordkeeping. The company is headquartered in Austin, Texas.
Sonnet BioTherapeutics stock logo

#6 - Sonnet BioTherapeutics

NASDAQ:SONN
Stock Price: $0.49 (+$0.01)
Market Cap: $13.39 million
Average Trading Volume: 6.32 million shares
Consensus Rating: Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $10.35 (1,999.4% Upside)
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer and is under phase 1 trial. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy and is under Phase Ib/IIa study; and SON-1210, a bispecific compound developed for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6. The company is headquartered in Princeton, New Jersey.
Minerva Surgical stock logo

#7 - Minerva Surgical

NASDAQ:UTRS
Stock Price: $0.25 (-$0.01)
PE Ratio: -0.27
Market Cap: $44.76 million
Average Trading Volume: 12.37 million shares
Consensus Rating: Hold (1 Buy Ratings, 0 Hold Ratings, 1 Sell Ratings)
Consensus Price Target: $1.00 (304.0% Upside)
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company offers Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.
T2 Biosystems stock logo

#8 - T2 Biosystems

NASDAQ:TTOO
Stock Price: $0.07 (-$0.01)
Market Cap: $2.05 million
Average Trading Volume: 41.99 million shares
Consensus Rating: Hold (0 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.50 (3,441.1% Upside)
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood test that identifies blood stream infections that causes sepsis and candidemia; T2Bacteria panel, a direct-from-blood test, which detects bacterial pathogens associated with sepsis; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2SARS-CoV-2 panel to detect SARS-CoV-2 virus. In addition, it is developing T2Biothreat panel for detection of biothreat pathogens; comprehensive sepsis panel to detect bloodstream infections caused by bacterial and Candida species, and antibiotic resistant markers; T2Cauris panel to provide direct detection of the emerging superbug Candida auris in patient skin, patient blood, and hospital environmental samples; and T2Lyme panel, a direct-from-blood test panel designed to run on the T2Dx Instrument to identify the bacteria that cause Lyme disease. The company was incorporated in 2006 and is headquartered in Lexington, Massachusetts.
Ideanomics stock logo

#9 - Ideanomics

NASDAQ:IDEX
Stock Price: $0.06
PE Ratio: -0.11
Market Cap: $46.04 million
Average Trading Volume: 48.94 million shares
Consensus Rating: Hold (0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
Ideanomics, Inc. engages in facilitating the adoption of commercial electric vehicles and development of financial services and fintech products. It operates through the following segments: Ideanomics Mobility, Ideanomics Energy, and Ideanomics Capital. The Ideanomics Mobility segment focuses on electric vehicles, including mid-and-last-mile delivery trucks and vans, tractors, and two-wheelers. The Ideanimics Energy is involved in charging and energy-related services. The Ideanomics Capital segment provides financing support to the company's Mobility and Energy business unit. The company was founded by Shane B. McMahon on October 19, 2004 and is headquartered in New York, NY.
WeWork stock logo

#10 - WeWork

NYSE:WE
Stock Price: $0.18
PE Ratio: -0.08
Market Cap: $392.31 million
Average Trading Volume: 13.12 million shares
Consensus Rating: Buy (4 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $4.83 (2,519.4% Upside)
WeWork Inc. provides flexible workspace solutions to individuals and organizations worldwide. The company offers workstation, private office, and customized floor solutions; and various amenities and services, such as private phone booths, internet, high-speed business printers and copiers, mail and package handling, front desk services, off-peak building access, common areas, and daily enhanced cleaning solutions. It also offers various value-add services; business and technical service solutions, including professional employer organization and payroll services, remote workforce solutions, human resources benefits, dedicated bandwidth, and IT equipment co-location solutions. In addition, the company offers workspace management solutions, which enable landlords and operators to power flexible spaces and provide direct access to an established customer base. As of December 31, 2021, its real estate portfolio includes 756 locations. WeWork Inc. was founded in 2010 and is headquartered in New York, New York.
Meta Materials stock logo

#11 - Meta Materials

NASDAQ:MMAT
Stock Price: $0.23 (-$0.01)
PE Ratio: -0.99
Market Cap: $111.19 million
Average Trading Volume: 6.75 million shares
Consensus Rating: Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $3.75 (1,554.2% Upside)
Meta Materials, Inc. engages in the manufacture and development of functional materials. It also provides nano-optic metamaterial technology for anti-counterfeiting security features. The company was founded by George Palikaras, Themos Kallos, and Nadine Geddes on October 30, 2007 and is headquartered in Dartmouth, Canada.
Airspan Networks stock logo

#12 - Airspan Networks

NYSE:MIMO
Stock Price: $0.22 (-$0.01)
PE Ratio: -0.21
Market Cap: $17.23 million
Average Trading Volume: 6.52 million shares
Consensus Rating: Hold (0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.00 (2,189.4% Upside)
Airspan Networks Holdings Inc. designs and produces wireless network equipment for 4G and 5G networks for mainstream public telecommunications service providers and private network implementations. It offers a range of 4G and 5G network build and network densification products with a portfolio of software and hardware tools for indoor and outdoor, compact femto, pico, micro, and macro base stations, as well as fixed wireless access and backhaul solutions portfolio for point-to-point and point-to-multipoint applications. The company serves mobile communications service providers, large enterprises, military communications integrators, and internet service providers. Airspan Networks Holdings Inc. is headquartered in Boca Raton, Florida.
Nutex Health stock logo

#13 - Nutex Health

NASDAQ:NUTX
Stock Price: $0.44 (-$0.03)
PE Ratio: -0.63
Market Cap: $309.90 million
Average Trading Volume: 2.24 million shares
Consensus Rating: Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $3.00 (574.3% Upside)
Nutex Health, Inc. operates technology-enabled healthcare services. It operates through the following segments: Hospital Division, Population Health Management Division, and Real State Division. The Hospital Division is involved in developing and operating a network of micro-hospitals, specialty hospitals and hospital outpatient departments providing comprehensive and high-quality 24/7 care. The Population Health Division establishes and operates independent physician associations and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real State Division includes owning a land and hospital buildings which are leased to the hospital entities The company was founded in 2011 and is headquartered in Houston, TX.
Aridis Pharmaceuticals stock logo

#14 - Aridis Pharmaceuticals

NASDAQ:ARDS
Stock Price: $0.27 (-$0.01)
PE Ratio: -0.12
Market Cap: $9.90 million
Average Trading Volume: 2.84 million shares
Consensus Rating: Buy (1 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $6.00 (2,085.8% Upside)
Aridis Pharmaceuticals, Inc. engages in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. Its products include AR-301, AR-101, AR-501, AR-712, AR-701, AR-401, AR-105 and AR-201. The company was founded by Eric J. Patzer and Vu L. Truong in 2003 and is headquartered in Los Gatos, CA.
Crown ElectroKinetics stock logo

#15 - Crown ElectroKinetics

NASDAQ:CRKN
Stock Price: $0.15 (+$0.01)
PE Ratio: -0.24
Market Cap: $7.15 million
Average Trading Volume: 5.19 million shares
Consensus Rating: Hold (0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
Crown Electrokinetics Corp. develops and sells optical switching films. The company also focuses on commercializing electrokinetic technology for use in the smart glass market. It offers electrokinetic film technology for smart or dynamic glass. The company was formerly known as 3D Nanocolor Corp. and changed its name to Crown ElectroKinetics Corp. in October 2017. Crown ElectroKinetics Corp. was incorporated in 2015 and is based in Corvallis, Oregon.
ObsEva stock logo

#16 - ObsEva

NASDAQ:OBSV
Stock Price: $0.08
PE Ratio: -0.09
Market Cap: $6.55 million
Average Trading Volume: 8.94 million shares
Consensus Rating: Hold (0 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $6.00 (7,042.9% Upside)
ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for women's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth. The company was founded by Ernest Loumaye and André Chollet on November 14, 2012 and is headquartered in Geneva, Switzerland.
Zomedica stock logo

#17 - Zomedica

NYSEAMERICAN:ZOM
Stock Price: $0.20
PE Ratio: -4.89
Market Cap: $194.03 million
Average Trading Volume: 3.59 million shares
Consensus Rating: Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $6.00 (2,969.1% Upside)
Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform and VetGuardian, a zero-touch vital signs remote monitoring system, as well as Revo Squared imaging platform comprising diagnostic imaging products and services for use in animal health. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan.
Agrify stock logo

#18 - Agrify

NASDAQ:AGFY
Stock Price: $0.21 (+$0.01)
PE Ratio: 0.00
Market Cap: $4.44 million
Average Trading Volume: 3.18 million shares
Consensus Rating: Hold (0 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $2.38 (1,010.3% Upside)
Agrify Corporation develops precision hardware and software cultivation and extraction solutions for the cannabis and hemp industry in the United States. The company offers vertical farming units and Agrify Insights Software-as-a-Service software; integrated grow racks and LED grow lights; and non-proprietary products designed, engineered, and manufactured by third parties, such as air cleaning systems and pesticide-free surface protection products. It also provides associated services comprising consulting, engineering, and construction. The company was formerly known as Agrinamics, Inc. and changed its name to Agrify Corporation in September 2019. Agrify Corporation was incorporated in 2016 and is headquartered in Billerica, Massachusetts.
Apexigen stock logo

#19 - Apexigen

NASDAQ:APGN
Stock Price: $0.47 (-$0.02)
Market Cap: $11.71 million
Average Trading Volume: 1.39 million shares
Consensus Rating: Buy (2 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $11.50 (2,321.6% Upside)
Apexigen Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody therapeutics for oncology. It develops a pipeline of product candidates, including APX005M, a humanized agonist antibody that is in Phase II clinical development for the treatment of solid tumors, such as melanoma, esophageal and gastroesophageal junction, sarcoma, and rectal and ovarian cancers in combination with immunotherapy, chemotherapy, radiation therapy, and cancer vaccines; and APX601, a humanized antagonist antibody that is in Phase I/II clinical trial for the treatment of multiple tumor indications, as well as APX801, an NK cell engager to activate natural killer cells to killing of tumor cells. The company was founded in 2010 and is based in San Carlos, California.
Bellicum Pharmaceuticals stock logo

#20 - Bellicum Pharmaceuticals

NASDAQ:BLCM
Stock Price: $0.37 (-$0.07)
Market Cap: $3.52 million
Average Trading Volume: 1.74 million shares
Consensus Rating: Hold (0 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: N/A
Bellicum Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on discovering and developing cellular immunotherapies for cancers and orphan inherited blood disorders. The firm uses its proprietary chemical induction of dimerization that controls components of the immune system in real time. Its product candidates include BPX-601, BPX-603, and Rivo-cel (rivogenlecleucel, formerly known as BPX-501). The company was founded by Kevin M. Slawin and David M. Spencer on July 14, 2004 and is headquartered in Houston, TX.
VIQ Solutions stock logo

#21 - VIQ Solutions

NASDAQ:VQS
Stock Price: $0.27 (+$0.02)
PE Ratio: -0.79
Market Cap: $8.45 million
Average Trading Volume: 2.34 million shares
Consensus Rating: Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.13 (319.5% Upside)
VIQ Solutions Inc. operates as a technology and service platform provider for digital evidence capture, retrieval, and content management in Australia, the United States, the United Kingdom, Canada, and internationally. It operates through two segments, Technology and Related Revenue, and Technology Services. The Technology and Related Revenue segment develops, distributes, and licenses computer-based digital solutions based on its technology. The Technology Services segment provides recording and transcription services. The company offers CapturePro that securely speeds the capture, creation, and management of large volumes of information, as well as preserves and secures the spoken word and video image, and delivers data; MobileMic Pro for capturing and managing incident reports, recorded statements, case notes, and other vital information; NetScribe, a comprehensive transcription creation and management platform that consolidates, accelerates, and optimizes workflows; aiAssist, a multi-tenant workflow and analysis platform to manage, convert, and analyze large volumes of audio and visual content; FirstDraft that converts audio files to text to provide access to interviews, testimonies, recorded calls, and dictations; and AccessPoint, a secure online portal that simplify court recording management, playback, and distribution. It also provides Carbon, a media-centric, and web-based platform that uses automatic speech-to-text; and Lexel, a cloud-based legal evidence management solution. In addition, the company provides legal, criminal justice, insurance, government, medical, corporate finance, media, and transcription services. VIQ Solutions Inc. was incorporated in 2004 and is headquartered in Mississauga, Canada.
AppHarvest stock logo

#22 - AppHarvest

NASDAQ:APPH
Stock Price: $0.35
PE Ratio: -0.21
Market Cap: $54.89 million
Average Trading Volume: 1.80 million shares
Consensus Rating: Hold (1 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.50 (329.6% Upside)
AppHarvest, Inc., an applied agricultural technology company, develops and operates indoor farms to grow non-GMO produce free of chemical pesticide residues. Its products include tomatoes; and other fruits and vegetables, such as berries, peppers, cucumbers, and salad greens. The company was incorporated in 2018 and is based in Morehead, Kentucky.
BIOLASE stock logo

#23 - BIOLASE

NASDAQ:BIOL
Stock Price: $0.07
PE Ratio: -0.02
Market Cap: $2.39 million
Average Trading Volume: 8.49 million shares
Consensus Rating: Buy (2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $5.63 (7,511.6% Upside)
BIOLASE, Inc. is a medical device company, which engages in the developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through the Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems use a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Lake Forest, CA.
Cyxtera Technologies stock logo

#24 - Cyxtera Technologies

NASDAQ:CYXT
Stock Price: $0.06
PE Ratio: -0.02
Market Cap: $11.72 million
Average Trading Volume: 9.61 million shares
Consensus Rating: Hold (3 Buy Ratings, 3 Hold Ratings, 2 Sell Ratings)
Consensus Price Target: $4.82 (7,433.5% Upside)
Cyxtera Technologies, Inc. provides various data center products and services for enterprises, service providers, and government agencies. It offers retail colocation, interconnection, deployment, and support services; and Bare Metal, an on-demand IT infrastructure solution. The company is headquartered in Coral Gables, Florida.
Organigram stock logo

#25 - Organigram

NASDAQ:OGI
Stock Price: $0.43 (+$0.01)
PE Ratio: -10.63
Market Cap: $135.16 million
Average Trading Volume: 1.43 million shares
Consensus Rating: Buy (1 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings)
Consensus Price Target: $1.67 (292.2% Upside)
OrganiGram Holdings, Inc. engages in the production and sale of medical marijuana. It focuses on producing cannabis for patients and adult recreational consumers. The firm's brands include Adult Recreational and Medical. The company was founded on July 5, 2010 and is headquartered in Moncton, Canada.

More Stock Ideas from MarketBeat

My Account -